Previous Article | Next Article ![]()
Journal of Virology, April 1999, p. 3227-3235, Vol. 73, No. 4
Evanston Northwestern Healthcare Research
Institute and Northwestern University, Evanston, Illinois 60201
Received 19 June 1998/Accepted 7 December 1998
Infection of susceptible mouse strains with BeAn, a less virulent
strain of Theiler's murine encephalomyelitis virus (TMEV), results in
immune system-mediated demyelinating lesions in the central nervous
system (CNS) similar to those in multiple sclerosis. Since macrophages
appear to carry the major detectable antigen burden in vivo, and
purification of sufficient cell numbers from the CNS for detailed
analysis is difficult, macrophage-like cell lines provide an accessible
system with which to study virus-macrophage interactions. The myeloid
precursor cell line M1 differentiates in response to cytokines and
expresses many characteristics of tissue macrophages. Incubation of
TMEV with undifferentiated M1 cells produced neither infection nor
apoptosis, whereas differentiated M1 (M1-D) cells developed a
restricted virus infection and changes indicative of apoptosis. Virus
binding and RNA replication as well as cellular production of
alpha/beta interferons increased with differentiation. Although the
amount of infectious virus was highly restricted, BeAn-infected M1-D
cells synthesized and appropriately processed virus capsid proteins at
levels comparable to those for permissive BHK-21 cells. Analysis of
Bcl-2 protein family expression in undifferentiated and differentiated
cells suggests that susceptibility of M1-D cells to apoptosis may be controlled, in part, by expression of the proapoptotic Theiler's murine encephalomyelitis
virus (TMEV), genus Cardiovirus, family
Picornaviridae, is a natural enteric pathogen of mice and
has been divided into two groups based on neurovirulence following
intracerebral inoculation of susceptible mouse strains. Infection with
BeAn, a less virulent strain of TMEV, results in a chronic, progressive
demyelinating disease of the central nervous system (CNS). Persistence
of BeAn within the CNS leads to immunopathologic damage of myelin,
mediated by major histocompatibility complex (MHC) class II-restricted
Th1 lymphocytes directed at a virus epitope(s) rather than host
neuroantigens (8, 14, 15, 30, 31).
During TMEV persistence, the major virus antigen burden resides in CNS
macrophages (M Analysis of M1 cell infection with the highly virulent GDVII and the
less virulent BeAn viruses revealed that only differentiated cells were
susceptible to infection and apoptosis, and as previously reported for
the restricted infection in BSC-1 cells (1), GDVII was a
more efficient inducer of apoptosis than BeAn virus. However, since
BeAn virus persists in mice and causes demyelination, subsequent studies focused on the less virulent BeAn virus. Interestingly, although BeAn infectious virus yields and viral RNA were lower in
differentiated M1 (M1-D) cells than in permissive BHK-21 cells, large
amounts of virus antigen were condensed within the cytoplasm of M1-D
cells. The data reported here suggest that myeloid cells are
susceptible to TMEV infection only when differentiated into M Cells, viruses, and reagents.
The M1 cell line, an immature
myelomonocytic cell line derived from the SL mouse strain (kind gift
from Selina Cheng Kang, Mount Sinai School of Medicine, and Barbara
Hoffman, Temple University), was maintained in RPMI 1640 supplemented
with 10% fetal bovine serum (GIBCO), 2 mM L-glutamine, 0.1 mg of kanamycin sulfate per ml, and nonessential amino acids (GIBCO)
(complete medium). Conditioned medium from mouse L929 cells, which
secrete M-CSF, was prepared by plating 0.5 × 106
cells in a T75 flask with 50 ml of Dulbecco modified Eagle medium (DMEM) supplemented as specified above for RPMI complete medium, harvesting the supernatant after 1 week, adding 50 ml fresh DMEM, and
collecting the supernatant after an additional week. Conditioned medium
from the IL-1-secreting mouse macrophage P388D1 cell line was prepared
by plating 1.5 × 106 cells in 15 ml of RPMI complete
medium, collecting the supernatant after 4 days, adding fresh medium,
and harvesting cells after an additional 4 days. Supernatants from both
time points were pooled, filtered, and stored at
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Differentiation of M1 Myeloid Precursor Cells into Macrophages
Results in Binding and Infection by Theiler's Murine Encephalomyelitis
Virus and Apoptosis
and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
isoform of
Bax and Bak. These data suggest that macrophage differentiation plays a
role in susceptibility to TMEV infection and apoptosis.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
s) (24, 36), and the virus load in M
s
isolated from the CNS equals that in clarified CNS homogenates (9). However, only a small percentage of M
s that
infiltrate demyelinating lesions contain detectable virus antigen
(24). We previously found that TMEV infection in two M
cell lines (RAW264.7 and P388D1) was restricted, and we postulated that
M
susceptibility to infection depends on the
differentiation/activation state of the M
(20). To
examine the cellular basis of the restrictive BeAn virus replication in
M
s, we used the myeloid precursor cell line M1, derived from a
spontaneous myeloid leukemia of SL mice (18, 19). M1 cells
differentiate in vitro into either M
- or granulocyte-like cells in
response to conditioned medium from embryonic cell cultures (18,
19), various cytokines (33, 34) including
interleukin-6 (IL-6) (7, 16, 42), macrophage colony-stimulating factor (M-CSF) (46), and chemicals such
as dexamethasone or 1
,23-dihydroxyvitamin D3
(22). Differentiated M1 cells upregulate several cell
surface proteins, including Fc receptors (FcR), (49), tumor
necrosis factor alpha receptors (29), and MHC class II
proteins, and they acquire functions such as phagocytosis and lysozyme
secretion (40). M1 myeloid precursor cells have been widely
used as a model for M
differentiation and gene regulation.
s and
that these cells die by apoptosis thereafter.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C until use. M1
cells were induced to differentiate with conditioned medium containing
20% L929 supernatant, 17% P388D1 supernatant, and 0.25%
2-
-mercaptoethanol (43a).
Virus infections. After adsorption of virus at a multiplicity of infection (MOI) of 10 for 45 min at 24°C, M1 cells were washed with phosphate-buffered saline (pH 7.2), cultured with complete RPMI containing 5% fetal bovine serum, and incubated at 37°C in a 5% CO2 incubator for the indicated times.
UV irradiation of BeAn. UV irradiation of BeAn virus was performed essentially as described elsewhere (21) except that the virus was exposed to UV for 1 or 20 min.
Flow cytometry. Staining for flow cytometry was done as described elsewhere (20). Briefly, nonspecific antibody binding to cells was blocked with 10 µl of goat serum and/or 2 µl of anti-CD32/16 (FcR) (PharMingen, San Diego, Calif.) where appropriate. TMEV antigens were detected by incubation with a 1:1,000 dilution of polyclonal rabbit anti-BeAn or normal rabbit serum for 30 min at 4°C, followed by a 1:200 dilution of fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit antibody (Cappel/Organon Teknika, Durham, N.C.) for 30 min at 4°C. Cytoplasmic BeAn antigen was detected as described elsewhere (20). Commercially available antibodies were used for the following antigens: CD32/CD16b, CD11A, CD29, CD51, and CD54 from PharMingen; and CD11b(C3bi) and F4/80 from Caltag Laboratories (San Francisco, Calif.). Antibody 2F8 was a kind gift from Siamon Gordon (Oxford, United Kingdom) (23). The MHC class II antibody was from hybridoma 10-3.6.2 (American Type Culture Collection, Rockville, Md.) which detects MHC class II k, v, q, and s haplotypes. The secondary antibodies were FITC-conjugated goat anti-rat immunoglobulin G (IgG; Caltag) and biotinylated anti-hamster Ig and avidin-FITC (PharMingen). After staining, cells were fixed in 1% paraformaldehyde and analyzed on a FACScan (Becton Dickinson, Palo Alto, Calif.) or a Coulter Epics XL-MCL (Coulter Corporation, Miami, Fla.). Data were evaluated by using the Consort 30 and LYSIS I computer programs for the FACScan or the Coulter computer program specific for the Epics.
Immunoprecipitation of viral proteins. Radiolabeled BeAn virus proteins were immunoprecipitated from cell lysates as described elsewhere (21) with 5 µl of polyclonal rabbit anti-BeAn antiserum, a concentration that is not limiting in these experiments.
[35S]methionine labeling and purification of BeAn virus. BeAn virus was labeled with [35S]methionine as described previously (20). Purified virus from infected BHK-21 cell lysates was used in a standard binding assay (12). Briefly, washed cells were resuspended (106 cells/ml) in DMEM containing 20 mM HEPES plus 1% bovine serum albumin and incubated on ice for 1 h prior to the addition of 35S-labeled BeAn (20,000 particles/cell). At the indicated times, an aliquot of the suspension was removed, diluted in DMEM containing 20 mM HEPES, and microcentrifuged at 12,000 × g for 30 s. The supernatant and cell-associated radioactivity were determined with a Beckman (Palo Alto, Calif.) model LS5000TD scintillation counter, and the percentage of cell-associated counts per minute was calculated by using Cricket Graph III software.
Assay of viral RNA replication. After virus adsorption, cells were washed and plated at 2 × 104 cells/100 µl/well in 96-microwell plates with complete medium containing actinomycin D (5 µg/ml) and [3H]uridine ([3H]UdR; 10 µCi/ml; specific activity, 15 to 25 Ci/mmol; ICN). Infected cells were incubated at 37°C for the indicated times and harvested on a PHD cell harvester (Cambridge Technologies, Watertown, Mass.), and radioactivity was determined with a Beckman model LS5000TD scintillation counter. Data were analyzed by using Cricket Graph III software.
Assay of caspase activity.
Caspases are members of the
IL-1
converting enzyme family of cysteine proteases, which cleave at
aspartic acid residues and are activated during apoptosis
(3). Caspase protease activity was measured in cell lysates
by using a modification of a described method (11). Briefly,
2 × 106 cells were lysed in 100 µl of buffer
containing 50 mM Tris-HCl (pH 7.4), 1 mM EDTA, 10 mM EGTA, and 10 µM
digitonin. Cells were suspended, incubated for 10 min at 37°C,
centrifuged to remove cellular debris, and assayed after 60 min of
incubation with 1 µM CPP32 substrate peptide acetyl-Asp-Glu-Val-Asp
conjugated to aminomethylcoumarin (DEVD-AMC). Fluorescence from cleaved
AMC was detected with a 7625 Microplate fluorometer (Cambridge
Technologies). Mean values of duplicate or triplicate samples are
reported after subtraction of background values.
IFN-
/
assay.
Biologically active alpha and beta
interferons (IFN-
/
) were measured essentially as described
elsewhere (39). L929 cells (104/well of a
96-well plate) were incubated overnight at 37°C in a humidified 5%
CO2 atmosphere and further incubated with serial twofold
dilutions of supernatants from mock- or BeAn-infected lysates for
6 h at 37°C. Vesicular stomatitis virus (105 PFU in
50 µl) was added to each well, and incubation continued until control
wells showed complete cytopathic effect (CPE). The IFN-
/
titer
was taken as the reciprocal of the dilution in which 50% of the cells
were protected from CPE. An IFN-
/
standard (Sigma, St. Louis,
Mo.) was added to each plate to determine the concentration (units per milliliter).
Immunoblotting for Bcl-2, Bcl-XL and Bax expression. Expression of Bcl-2, Bcl-XL, and Bax proteins was assessed by Western blotting. Cells were lysed in radioimmunoprecipitation assay buffer and clarified by low-speed centrifugation to remove nuclei and debris. Protein content was determined with Bio-Rad (Hercules, Calif.) DC protein assay kit according to the manufacturer's instructions. Samples (20 µg/lane) were electrophoresed on a 12 or 15% polyacrylamide gel and transferred to a ProBlot membrane (Applied Biosystems, Foster City, Calif.). The membrane, blocked with Tris-buffered saline containing 5% nonfat dry milk and 0.02% Tween 20, was incubated with 1:1,000 dilution of polyclonal rabbit anti-Bcl-2, anti-Bcl-X, and anti-Bax antiserum (PharMingen) for 2 h at 4°C, followed by a 60-min incubation with a 1:1,000 dilution of peroxidase-labeled anti-rabbit IgG. Peroxidase-labeled proteins were detected with 3,3'-diaminobenzidine tetrahydrochloride (Amresco, Solon, Ohio) in the presence of 0.1% peroxide.
RPA.
RNA was isolated from M1 and M1-D cells by using
TRIZOL reagent (Life Technologies, Grand Island, N.Y.)
according to the manufacturer's instructions. The RiboQuant multiprobe
RNase protection assay (RPA) (PharMingen) was used according to the
manufacturer's instructions to analyze RNA expression of
bcl-2 family members, using the mAPO-2 template set from
PharMingen (catalog no. 45354P). The probe was synthesized by using
[
-35S]UTP instead of [
-32P]UTP.
| |
RESULTS |
|---|
|
|
|---|
In vitro differentiation of M1 cells.
M1 cells differentiate
to M
-like cells in vitro in response to a number of stimuli,
including IL-6, M-CSF, and IL-1 (7, 33, 34, 40, 46). When M1
cells were exposed to conditioned medium containing cytokines, cell
morphology changed from round, nonadherent cells to bipolar, flattened
adherent cells (Fig. 1A and B). Flow
cytometry confirmed this change in morphology, with an ~2-fold
increase in both size (shift in forward scatter from 24 to 41 U) and
granularity (shift in side scatter from 10.5 to 21 U). Treatment of
M1-D cells with IFN-
(100 U/ml; Genzyme, Cambridge, Mass.) resulted
in even larger, more adherent cells with numerous cytoplasmic vacuoles
(Fig. 1C). These cells increased an additional 1.5-fold in size and
granularity (data not shown). Thus, M1 cells grown in conditioned
medium were not terminally differentiated and remained responsive to an
additional cytokine signal.
|
-specific markers, including MHC class II proteins (Fig.
1D), FcR (CD32/CD16) (40) (Fig. 1E), F4/80 (28),
Mac-1 (43), and 2F8 (10) (Table
1), were expressed concomitant with the
morphological changes in M1 cells grown in conditioned medium. Of the
other surface proteins tested, the integrin
1 chain
(CD29) was upregulated, the integrin
v chain (CD51) was not expressed in either the undifferentiated or differentiated population, and I-CAM (CD54) was highly expressed on both cell populations (Table 1). Together, these data indicate that M1 cells
undergo differentiation to M
-like cells in the presence of
conditioned medium. This differentiated state has been stable for 12 months with or without continuous exposure to conditioned medium.
|
Virus-induced apoptosis of M1-D cells. When M1 and M1-D cells were infected with BeAn virus at an MOI of 10, only the M1-D cells showed CPE after 18 h, with adherent cells rounding and detaching from the plate. Phase contrast microscopy revealed cell shrinkage and prominent surface blebbing consistent with active cell death by apoptosis. Indeed, DNA staining with 4',6-diamidino-2-phenylindole (DAPI) revealed condensed nuclei and distinct apoptotic bodies in M1-D cells (Fig. 2B), whereas the nuclear morphology in M1 cells remained intact with clear chromatin structure (Fig. 2A). Counterstaining of these cells delineated virus antigen in 70 to 90% of M1-D cells (see Fig. 4A), which was present as a compact mass in condensed cells (Fig. 2B). Analysis of DNA cleavage into nucleosome-sized bands, a hallmark of apoptosis, showed clear fragmentation in DNA isolated from supernatants of BeAn-infected M1-D cells but not in uninfected M1-D or infected undifferentiated M1 cells (Fig. 2C).
|
s became susceptible to BeAn virus
infection during differentiation and that infection results in apoptosis.
As previously demonstrated with BSC-1 cells (a primate kidney cell
line) (21), infection with the highly virulent GDVII virus
resulted in significant apoptosis in M1-D cells at a 1-log-lower MOI
than for BeAn (data not shown).
BeAn virus binding.
Flow cytometry revealed BeAn virus binding
to the surface of M1-D cells (0.5 to 1.0 log increase in mean
fluorescence intensity) but not to M1 cells (background fluorescence)
(Fig. 3A). In direct analysis of virus
binding with 35S-labeled BeAn (Fig. 3B), the maximum
binding to M1-D cells after 60 min was similar to that of permissive
BHK-21 cells (40 to 50%) and approximately fivefold greater than that
for the undifferentiated M1 cells (10%), consistent with the flow
cytometry result. BeAn binding to M1-D cells rapidly increased with
time, while binding to M1 cells remained close to background levels (5 to 10%), as measured in a variant, BeAn-uninfectable BHK-21 cell line
developed in this laboratory (unpublished observations). These data
suggest upregulation of the molecule(s) that binds BeAn virus in
differentiated M
s.
|
Expression of BeAn virus proteins. To obtain a relative measure of the virus antigen observed by fluorescence microscopy in BeAn-infected M1-D cells (Fig. 2B), cytoplasmic BeAn virus antigen was measured by flow cytometry 20 h after infection. When M1 and M1-D cells were permeabilized with 0.3% saponin and stained with a polyclonal rabbit anti-BeAn serum, only M1-D cells expressed large amounts (37.5-fold increase) of virus antigen (mean fluorescence intensities of M1 and M1-D cells, 0.8 and 30 relative fluorescence units, respectively [Fig. 4A]). Immunoprecipitation of virus proteins from BeAn-infected permissive BHK-21, M1, and M1-D cells with a polyclonal rabbit anti-BeAn serum (Fig. 4B) revealed similar amounts of radioactive virus capsid proteins from 106 cell equivalents of M1-D and permissive BHK-21 cells. Densitometric scans of the two immunoprecipitates revealed similar levels of intensity for each virus capsid protein in the two populations (data not shown). No virus antigen was precipitated in infected undifferentiated M1 cells (Fig. 4B) or in uninfected M1-D cells (data not shown). These data indicate that M1-D cells were infected and virus capsid proteins were generated at levels comparable to those in permissive BHK-21 cells.
|
BeAn virus RNA replication and production of infectious virus. BeAn virus RNA replication was measured by incorporation of [3H]UdR in actinomycin D-treated M1 and M1-D cells; uninfected cells were assayed simultaneously to obtain background incorporation (Fig. 4C). Only BeAn-infected M1-D cells incorporated significant amounts of radioactivity above uninfected controls. The amount of radioactivity incorporated in M1 cells did not differ significantly in infected or uninfected cells, although background levels were higher than in M1-D cells. Compared to permissive BHK-21 cells, which routinely incorporate 30,000 to 50,000 cpm at the peak of virus RNA replication, M1-D cells were highly restricted, never exceeding 3,500 cpm with four different preparations of M1-D cells in six experiments. Nevertheless, virus RNA replication was, on average, 5.9-fold greater in infected M1-D than in M1 cells. Virus RNA levels in BHK-21 cells peaked between 10 and 12 h, increasing only slightly by 24 h (not shown), whereas the levels in M1-D cells peaked between 8 and 10 h and declined thereafter. It is possible that virus RNA is degraded in differentiated M1-D cells upon induction of apoptosis and activation of RNases (5, 6). Virus titers in infected cell populations at 20 h were low, ranging from 2 to 10 PFU/cell for M1-D cells and background levels for M1 cells. Thus, virus production in M1-D cells was present but highly restricted compared to permissive BHK-21 cells, which produce 70 PFU/cell 6 h after infection (20).
To demonstrate that virus replication is required for the induction of apoptosis, M1-D cells were infected with UV-inactivated BeAn virus. Cell surface binding of UV-inactivated BeAn virus to M1-D cells was similar to that of untreated virus (Fig. 5A). In fact, UV treatment for 20 min appeared to enhance virus binding somewhat. When assayed for cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (21) at high MOI (Fig. 5B), less than 5% of M1-D cells infected with untreated BeAn virus remained viable. UV inactivation for 1 min reduced cell death, with greater than 90% of the cells remaining viable at an MOI of 25; however, at an MOI of 100, cell viability was 50%. UV inactivation for 20 min essentially destroyed the virus's ability to induce apoptosis even at an MOI of 100, with no change in the ability of the virus to bind to the surface of M1-D cells. These data indicate that virus RNA replication is necessary for the induction of apoptosis by BeAn virus.
|
IFN-
/
secretion.
To test whether constitutive secretion
of IFN-
/
contributed to resistance to (M1) or restriction of
(M1-D) BeAn virus infection, levels of these cytokines were measured in
supernatants of uninfected M1 and M1-D cells (Table
2). Supernatants from M1 precursor cells contained undetectable amounts of IFN-
/
(less than 10 U/ml), whereas ~500 U/ml was detected in supernatants from M1-D cells. Secretion of IFN-
/
could be induced in both cell populations with
IFN-
treatment (100 U/ml). Thus, M1-D cells may already secrete
sufficient levels prior to BeAn infection to slow virus RNA replication
and allow cells time to respond by apoptosis. The morphological
characteristics and increased IFN-
/
levels after IFN-
treatment of M1-D cells resemble those of resident M
s which can also
be activated after an additional cytokine signal (4).
|
Bcl-2, Bcl-XL, and Bax expression.
To determine
whether Bcl-2 proteins, which regulate apoptosis (17), play
a role in the sensitivity of M1-D cells to infection and apoptosis,
Western blotting of lysates from cells before and after infection and
IFN-
treatment was performed with antibodies to Bcl-2, Bcl-X, and
Bax (Fig. 6). Bcl-2 was expressed in M1
cells independent of infection or IFN-
treatment; however, in M1-D cells, Bcl-2 expression was lost and not regained upon infection or
IFN-
treatment. The antiapoptotic Bcl-XL showed the
opposite pattern of expression, i.e., high levels of M1-D cells and low levels of M1 cells regardless of infection or IFN-
treatment. Expression of the proapoptotic Bcl-XS protein, an
alternatively spliced variant of Bcl-X, was not observed (not shown).
In contrast, the proapoptotic
isoform of Bax, whose expression has
been shown to correlate with accelerated apoptosis (32), was
found only in M1-D cells. Bax-
, whose function is unclear, was
ubiquitously expressed under all conditions. However, in two
independently derived populations of M1-D, IFN-
treatment resulted
in the loss of Bax-
expression. The significance of this finding is
unknown. These data indicate that expression of the Bcl-2 family of
proteins is modulated during differentiation or activation of M1 cells, consistent with their increased susceptibility to apoptosis
(25).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Our data using an in vitro model of M
differentiation are
consistent with the hypothesis that the state of M
differentiation influences the susceptibility of these cells to infection and apoptosis. Previous experiments using the highly virulent GDVII virus and transformed macrophage cell lines revealed that the M1 cells
were resistant to infection, whereas two other macrophage cell lines
were susceptible (20). The M1 cell line allowed us to ask
the specific question of whether direct differentiation of a myeloid
precursor cell line in vitro affected the cells' ability to be
infected. Preliminary experiments using both GDVII and BeAn virus to
infect M1-D cells showed results similar to previously published data
using BSC-1 cells (21).
After exposure to conditioned medium, the myeloid precursor M1 cells
acquired characteristics similar to those of resident M
s (Fig. 1;
Table 1). At this stage of differentiation, M1-D cells were observed to
bind BeAn virus, become infected, and undergo apoptosis. The data
suggest that virus entry into undifferentiated M1 cells is blocked at
the receptor level. Proof that M1 cells can support BeAn virus
infection and die by apoptosis awaits transfection of BeAn virus RNA
into these cells, although to date, transfection efficiencies (<1.0%)
have been too low for analysis.
Infection at an MOI of 10 statistically guarantees that each cell is infected with at least one infectious virus particle. The flow cytometry data for infected M1-D cells indicate that 70 to 90% of the cells contain virus antigen. This discrepancy could be due to (i) a low estimate of the antigen-containing cells by flow cytometry or (ii) a resistant subpopulation of cells. Microscopic examination of infected M1-D cells indicates that nearly 90% of the cells contain virus antigen. Since these cells are neither clonal nor synchronized in their cell cycle, there may be a subpopulation of M1-D cells that are resistant to infection. This observation is being investigated further.
Other viruses in which M
differentiation determines susceptibility
to infection have been described: visna virus infects M
s but not
monocytes (13), equine infectious anemia virus RNA is found
only in resident M
s and not in peripheral blood monocytes (41), herpes simplex virus type 1 infects differentiated
human U937 monocytoid cells but not undifferentiated cells
(45), and Puumula virus produces more infectious virus in
differentiated U937 than in undifferentiated cells (44).
However, our system reveals an interesting paradox paralleling TMEV
persistence in the CNS of susceptible mice. Although virus antigen was
readily observed in the cytoplasm of the infected M1-D cells (Fig. 2, 4A, and 4B), viral RNA and production of infectious virus particles were highly restricted. This finding suggests that abundant virus capsid proteins are synthesized without assembly into infectious virus
particles. There are several possible explanations for this observation, including insufficient transcription of viral RNA molecules for packaging into viral particles, defective assembly of
capsid proteins into packaging intermediates, i.e., protomers and/or
pentamers, and/or a block in virus RNA replication and virion assembly
by an as yet unidentified cellular mechanism, perhaps related to
apoptosis. Experiments to define the relevant mechanisms are being
pursued in our laboratory. Preliminary experiments suggest that virus
assembly in M1-D cells is altered.
It is also possible that M1 cells are inherently resistant to BeAn virus-induced apoptosis due to a high level of Bcl-2 expression (Fig. 5). Lotem and Sachs (25) have also reported that M1 cells express Bcl-2 and resist apoptosis induction by adriamycin and cycloheximide. Recently, Van Der Vliet et al. (47) showed that neutrophils in human peripheral blood had high Bax/Bcl-2 ratios, while monocytes and lymphocytes had relatively low ratios, and that susceptibility to anti-Fas-induced apoptosis correlated with the ratios. These data suggest that monocytes, in vivo, are inherently more resistant to apoptosis than neutrophils.
We examined protein expression of only 3 of the 15 known Bcl-2 family
members based on previous data (23). Our results showing that undifferentiated cells express Bcl-2, while differentiated cells
express Bcl-XL, are consistent with those of Lotem and
Sachs (25). However, in contrast to that study, we observed
upregulation, not downregulation, of Bax-
protein expression. This
discrepancy may be explained by the difference in either
differentiation protocols or detection methods. In addition, RPA
confirmed the immunoblot results, including upregulation of
bax. An additional proapoptotic RNA, bak,
appeared to be upregulated by RPA analysis as well. Our data are
consistent with an increased susceptibility to apoptosis after
differentiation, although we cannot exclude a potential role for other
members of the Bcl-2 family. However, we can exclude a regulatory role
for Bcl-2, since overexpression of bcl-2 in M1-D cells did
not affect the ability of the virus to induce apoptosis (data not shown).
A possible mechanism for the maintenance of an inflammatory response
despite low virus titers is suggested by the fact that virus capsid
proteins were abundant in apoptotic M1-D cells. It is possible that
virus antigens contained in apoptotic corpses are phagocytized by
macrophages and made available for presentation to T cells. Bellone et
al. (5) recently reported that antigen-specific cytotoxic T
cells were activated by peritoneal macrophages that phagocytized
antigen-expressing apoptotic cells. An earlier study (35)
reported the detection of Sindbis virus glycoproteins in the surface
blebs of apoptotic infected HeLa cells. Recently dendritic cells have
been shown to acquire antigen from apoptotic cells and present them to
both class I and class II-restricted T cells (2, 37).
Therefore, it seems possible that phagocytosis of virus
protein-containing M
s by MHC class II-expressing M
s or CNS
microglia could maintain an immune response with very few productively
infected cells but with sufficient virus antigen to trigger a T-cell
response. This possibility is being tested in assays using apoptotic
M1-D cells as phagocytic targets for peritoneal macrophages from
TMEV-susceptible mice.
| |
ACKNOWLEDGMENTS |
|---|
This work supported by NIH grant NS21913 and the Leiper Foundation.
We thank Shannon Hertzler for the radioactive virus binding data and Shiaolan Yang and George Twaddle for helpful discussions.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Evanston Northwestern Research Institute, Women's Hospital, B654, 2650 Ridge, Evanston, IL 60201. Phone: (847) 570-2378. Fax: (847) 570-1568. E-mail: mlj461{at}nwu.edu.
Present address: St. Antonius Clinic, Wuppertal, Germany.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Adams, J. M., and S. Cory.
1998.
The Bcl-2 protein family:arbiters of cell survival.
Science
281:1322-1326 |
| 2. | Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89[Medline]. |
| 3. | Alnemri, E. S., D. J. Livingston, D. W. Nicholson, G. Salvesen, N. A. Thornberry, W. W. Wong, and J. Yuan. 1996. Human ICE/CED-3 protease nomenclature. Cell 87:171[Medline]. |
| 4. | Auger, M. J., and J. A. Ross. 1992. The biology of the macrophage, p. 3-74. In C. E. Lewis, and J. O. McGee (ed.), The natural immune system: the macrophage. IRL Press, New York, N.Y. |
| 5. | Bellone, M., G. Iezzl, P. Rovere, G. Galati, A. Ronchetti, M. P. Protti, J. Davoust, C. Rugarli, and A. A. Manfredi. 1997. Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159:5391-5399[Abstract]. |
| 6. |
Castelli, J. C.,
B. A. Hassel,
K. A. Wood,
X. Li,
K. Amemiya,
M. C. Dalakas,
P. F. Torrence, and R. J. Youle.
1997.
A study of the interferon antiviral mechanism:apoptosis activation by the 2-5A system.
J. Exp. Med.
186:967-972 |
| 7. | Chlu, C., and F. Lee. 1989. IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells. J. Immunol. 142:1909-1915[Abstract]. |
| 8. | Clatch, R. J., H. L. Lipton, and S. D. Miller. 1986. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J. Immunol. 138:920-926. |
| 9. | Clatch, R. J., S. D. Miller, R. Metzner, M. C. Dal Canto, and H. L. Lipton. 1990. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176:244-254[Medline]. |
| 10. | daSilva, R. P., N. Platt, W. J. S. deVilliers, and S. Gordon. 1996. Membrane molecules and macrophage endocytosis: scavenger receptor and macrosialin as markers of plasma-membrane and vacuolar functions. Biochem. Soc. Trans. 24:221-224. |
| 11. | Enari, M., R. V. Talanian, W. W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723-726[Medline]. |
| 12. | Fotladis, C., D. R. Kilpatrick, and H. L. Lipton. 1991. Comparison of the binding characteristics to BHK-21 cells of viruses representing the two Theiler's virus neurovirulence groups. Virology 182:365-370[Medline]. |
| 13. |
Gendelman, H. E.,
O. Narayan,
S. Kennedy-Stoskopf,
P. G. E. Kennedy,
Z. Ghotbi,
J. E. Clements,
J. Stanley, and G. Pezeshkpour.
1986.
Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages.
J. Virol.
58:67-74 |
| 14. | Gerety, S. J., W. J. Karpus, A. R. Cubbon, R. G. Goswaml, M. K. Rundell, J. D. Peterson, and S. D. Miller. 1994. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. J. Immunol. 152:908-918[Abstract]. |
| 15. | Gerety, S. J., K. M. Rundell, M. C. Dal Canto, and S. D. Miller. 1994. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. J. Immunol. 152:919-929[Abstract]. |
| 16. | Gothelf, Y., J. Raber, L. Chen, A. Schattner, J. Chebath, and M. Revel. 1991. Terminal differentiation of myeloleukemic M1 cells induced by IL-6: role of endogenous interferon. Lymphokine Cytokine Res. 10:369-375[Medline]. |
| 17. | Hawkins, C. J., and D. L. Vaux. 1997. The role of the Bcl-2 family of apoptosis regulatory proteins in the immune system. Semin. Immunol. 9:25-33[Medline]. |
| 18. | Ichikawa, Y. 1969. Differentiation of a cell line of myeloid leukemia. J. Cell. Physiol. 74:223-234[Medline]. |
| 19. | Ichikawa, Y. 1970. Further studies on the differentiation of a cell line of myeloid leukemia. J. Cell. Physiol. 76:175-184[Medline]. |
| 20. | Jelachich, M. L., P. Bandyopadhyay, K. Blum, and H. L. Lipton. 1995. Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation. Virology 209:437-444[Medline]. |
| 21. |
Jelachich, M. L., and H. L. Lipton.
1996.
Theiler's murine encephalomyelitis virus kills restrictive but not permissive cells by apoptosis.
J. Virol.
70:6856-6861 |
| 22. |
Kasukabe, T.,
J. Okabe-Kado,
Y. Honma, and M. Hozuml.
1991.
Interleukin-4 inhibits the differentiation of mouse myeloid leukemia M1 cells induced by dexamethasone, D-factor/leukemia inhibitory factor and interleukin- , but not by 1 ,25-dihydroxyvitamin D3.
FEBS Lett.
291:181-184[Medline].
|
| 23. | Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620[Medline]. |
| 24. | Lipton, H. L., G. Twaddle, and M. L. Jelachich. 1995. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 69:2525-2533[Abstract]. |
| 25. | Lotem, J., and L. Sachs. 1995. Regulation of bcl-2, bcl-XL, and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Differ. 6:647-653[Abstract]. |
| 26. | Mangan, D. F., and S. M. Wahl. 1991. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and proinflammatory cyokines. J. Immunol. 147:3408-3412[Abstract]. |
| 27. | Mangan, D. F., G. R. Welch, and S. M. Wahl. 1991. Lipopolysaccharide, tumor necrosis factor-a, and IL-1b prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146:1541-1546[Abstract]. |
| 28. |
McKnight, A. J.,
A. J. Mcfarlane,
P. Dir,
L. Turley,
A. C. Willis, and S. Gordon.
1997.
Molecular cloning of F4/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane hormone receptor family.
J. Biol. Chem.
271:486-489 |
| 29. |
Michishita, M.,
Y. Yoshido,
H. Uchino, and K. Nagata.
1990.
Induction of tumor necrosis factor-a and its receptors during differentiation in myeloid leukemic cells along the monocytic pathway: a possible regulatory mechanism for TNF-a production.
J. Biol. Chem.
265:8751-8759 |
| 30. | Miller, S. D., R. J. Clatch, D. C. Pevear, J. L. Trotter, and H. L. Lipton. 1987. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. J. Immunol. 138:3776-3784[Abstract]. |
| 31. | Miller, S. D., S. J. Gerety, M. K. Kennedy, J. D. Peterson, J. L. Trotter, V. K. Touhy, C. Waltenbaugh, M. C. Dal Canto, and H. L. Lipton. 1989. Class-II restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. J. Neuroimmunol. 26:9-23. |
| 32. | Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619[Medline]. |
| 33. |
Onozaki, K.,
T. Tamatani,
T. Hashimoto, and K. Matsushima.
1987.
Growth inhibition and augmentation of mouse myeloid leukemic cell line differentiation by interleukin-1.
Cancer Res.
47:2397-2402 |
| 34. | Onozaki, K., H. Urawa, T. Tamatani, Y. Iwamura, T. Hashimoto, T. Baba, H. Suzuki, M. Yamada, S. Yamamoto, J. J. Oppenheim, and K. Matsushima. 1997. Synergistic interactions of interleukin 1, interferon-b, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1): evidence that interferon-b is an autocrine differentiating factor. J. Immunol. 140:112-119[Abstract]. |
| 35. |
Rosen, A.,
L. Casciola-Rosen, and J. Ahearn.
1995.
Novel packages of viral and self-antigens are generated during apoptosis.
J. Exp. Med.
181:1557-1561 |
| 36. | Rossi, C. P., M. Delcroix, I. Huitinga, A. McAllister, N. van Rooijen, E. Claassen, and M. Brahic. 1997. Role of macrophages during Theiler's virus infection. J. Virol. 71:3336-3340[Abstract]. |
| 37. |
Rovere, P.,
C. Vallinoto,
A. Bondanza,
M. C. Crosti,
P. Ciardi-Castagnoll,
C. Rugarli, and A. A. Manfredl.
1998.
Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function.
J. Immunol.
161:4467-4471 |
| 38. | Rozhon, E. J., J. D. Kratochvil, and H. L. Lipton. 1983. Analysis of genetic variation in Theiler's virus during persistent infection in the mouse central nervous system. Virology 128:16-32[Medline]. |
| 39. |
Rubinstein, S.,
P. C. Famillietti, and S. Pestka.
1981.
Convenient assay for interferons.
J. Virol.
37:755-758 |
| 40. | Ruhl, S., and D. H. Pluznik. 1993. Dissociation of early and late markers of murine myeloid differentiation by interferon-gamma and interleukin-6. J. Cell. Physiol. 155:130-138[Medline]. |
| 41. |
Sellon, D. C.,
S. T. Perry,
L. Coggins, and F. J. Fuller.
1992.
Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes.
J. Virol.
66:5906-5913 |
| 42. |
Shabo, Y.,
J. Lotem,
M. Rubinstein,
M. Revel,
S. C. Clark,
S. F. Wolf,
R. Kamen, and L. Sachs.
1988.
The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6.
Blood
72:2070-2073 |
| 43. | Springer, T., G. Galfre, D. S. Secher, and C. Milstein. 1979. A Mac-1 macrophage differentiation antigen identified by a monoclonal antibody. Eur. J. Immunol. 9:301-306[Medline]. |
| 43a. | Steinberg, T. (Washington University School of Medicine, St. Louis, Mo.). Personal communication. |
| 44. |
Temonen, M.,
H. Lankinen,
O. Vapalahti,
T. Ronni,
I. Julkunen, and A. Vaheri.
1995.
Effect of interferon- and cell differentiation on Puumala virus infection in human monocyte/macrophages.
Virology
206:8-15[Medline].
|
| 45. | Tenney, D. J., and P. S. Morahan. 1987. Effects of differentiation of human macrophage-like U937 cells on intrinsic resistance to herpes simplex type 1. J. Immunol. 139:3076-3083[Abstract]. |
| 46. |
Tauda, H.,
L. M. Neckers, and D. H. Pluznik.
1986.
Colony stimulating factor-induced differentiation of murine M1 myeloid leukemia cells is permissive in early G1 phase.
Proc. Natl. Acad. Sci. USA
83:4317-4321 |
| 47. | Van Der Vliet, H. J., P. C. Wever, F. N. Van Diepen, S. L. Yong, and I. J. Ten Berge. 1997. Quantification of Bax/Bcl2-ratios in peripheral blood lymphocytes, monocytes and granulocytes and their relation to susceptibility to anti-Fas (anti-CD95)-induced apoptosis. Clin. Exp. Immunol. 110:324-328[Medline]. |
| 48. | van Furth, R. 1989. Origin and turnover of monocytes and macrophages. Curr. Top. Pathol. 79:125-150[Medline]. |
| 49. | Yodoi, J., T. Masuda, M. Miyama, M. Maeda, and Y. Ichikawa. 1978. Interaction of lymphocytes and macrophage cell line cells (M1 cells). 1. Functional maturation and appearance of Fc receptors in M1 cells. Cell. Immunol. 39:5-17[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|